Assembly Biosciences, Inc. (ASMB) Stock Price & Growth Analysis

Quote Panel

Updated October 23, 2025

1W -4.41 % 1M 9.70 % 3M 52.57 % 1Y 66.27 %

Key Metrics

Market Cap
215.97M
Shares Outstanding
7.67M
Share in Float
3.59M
Dividende
0

Earning Date
06 Nov 2025
Price Target
28.15
Average Volume
144196
Beta
0.613

Range
7.75-31.12
Industry
Biotechnology
Website
https://www.assemblybio.com
Sector
Healthcare

Quote Panel

Updated October 23, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

9.07x

P/S Ratio

11.81x

P/B Ratio

0.2

Debt/Equity

-165.0%

Net Margin

$-5.6

EPS

How ASMB compares to sector?

P/E Ratio

Fundamentals

Relative Strength

ASMB

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$23M

-33%

2026-Revenue

$3.90

-3%

2026-EPS

$13M

33%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

38.00(34.99%)

Number of analyst

Last analyst upgrade/downgrade

Citigroup

initialise

Previous: Not converted

2025-09-24

Now: Outperform

Guggenheim

initialise

Previous: Not converted

2025-03-25

Now: Buy

Jefferies

upgrade

Previous: Not converted

2024-09-20

Now: Buy

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.23

N/A

-3.24
vs -5.76

Q4.23

N/A

-2.15
vs -5.52

Q1.24

N/A

-1.66
vs -4.44

Q2.24

N/A

-1.98
vs -3.84

Q3.24

N/A

-1.51
vs -3.24

Q4.24

N/A

-1.57
vs -2.15

Q1.25

N/A

-1.17
vs -1.66

Q2.25

N/A

-1.33
vs -1.98

Q3.25

N/A

-0.82
vs -1.51

Q4.25

N/A

-0.80
vs -1.57

Sales Growth

YoY

Current

Estimates

Q3.23

NA vs NA

Q4.23

7.2M vs NA

Q1.24

5.8M vs NA

Q2.24

8.5M vs NA

Q3.24

6.8M vs NA

Q4.24

+3%

7.4M vs 7.2M

Q1.25

+63%

9.4M vs 5.8M

Q2.25

-100%

NA vs 8.5M

Q3.25

+9%

7.5M vs 6.8M

Q4.25

+1%

7.5M vs 7.4M

Return on Equity

QoQ

Q1.23

-26%

-0.26
vs -0.26

Q2.23

-31%

-0.31
vs -0.26

Q3.23

-35%

-0.35
vs -0.31

Q4.23

-27%

-0.27
vs -0.35

Q1.24

-28%

-0.28
vs -0.27

Q2.24

-32%

-0.32
vs -0.28

Q3.24

-37%

-0.37
vs -0.32

Q4.24

-31%

-0.31
vs -0.37

Q1.25

-32%

-0.32
vs -0.31

Q2.25

-56%

-0.56
vs -0.32

Institutionnal Ownership

QoQ

Q1.23

37
vs 39

-5%

Q2.23

31
vs 37

-16%

Q3.23

32
vs 31

Q4.23

44
vs 32

38%

Q1.24

24
vs 44

-45%

Q2.24

28
vs 24

17%

Q3.24

30
vs 28

Q4.24

35
vs 30

17%

Q1.25

36
vs 35

Q2.25

34
vs 36

-6%

Earnings Growth

YoY

Current

Estimates

Q3.23

N/A

-3.24
vs -5.76

Q4.23

N/A

-2.15
vs -5.52

Q1.24

N/A

-1.66
vs -4.44

Q2.24

N/A

-1.98
vs -3.84

Q3.24

N/A

-1.51
vs -3.24

Q4.24

N/A

-1.57
vs -2.15

Q1.25

N/A

-1.17
vs -1.66

Q2.25

N/A

-1.33
vs -1.98

Q3.25

N/A

-0.82
vs -1.51

Q4.25

N/A

-0.80
vs -1.57

Sales Growth

YoY

Current

Estimates

Q3.23

NA vs NA

Q4.23

7.2M vs NA

Q1.24

5.8M vs NA

Q2.24

8.5M vs NA

Q3.24

6.8M vs NA

Q4.24

+3%

7.4M vs 7.2M

Q1.25

+63%

9.4M vs 5.8M

Q2.25

-100%

NA vs 8.5M

Q3.25

+9%

7.5M vs 6.8M

Q4.25

+1%

7.5M vs 7.4M

Return on Equity

QoQ

Q1.23

-26%

-0.26
vs -0.26

Q2.23

-31%

-0.31
vs -0.26

Q3.23

-35%

-0.35
vs -0.31

Q4.23

-27%

-0.27
vs -0.35

Q1.24

-28%

-0.28
vs -0.27

Q2.24

-32%

-0.32
vs -0.28

Q3.24

-37%

-0.37
vs -0.32

Q4.24

-31%

-0.31
vs -0.37

Q1.25

-32%

-0.32
vs -0.31

Q2.25

-56%

-0.56
vs -0.32

Institutionnal Ownership

QoQ

Q1.23

37
vs 39

-5%

Q2.23

31
vs 37

-16%

Q3.23

32
vs 31

Q4.23

44
vs 32

38%

Q1.24

24
vs 44

-45%

Q2.24

28
vs 24

17%

Q3.24

30
vs 28

Q4.24

35
vs 30

17%

Q1.25

36
vs 35

Q2.25

34
vs 36

-6%

Earnings Growth

Forecast

$23M

-33%

2026-Revenue

$3.90

-3%

2026-EPS

$13M

33%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

38.00(34.99%)

Number of analyst

Last analyst upgrade/downgrade

Citigroup

initialise

Previous: Not converted

2025-09-24

Now: Outperform

Guggenheim

initialise

Previous: Not converted

2025-03-25

Now: Buy

Jefferies

upgrade

Previous: Not converted

2024-09-20

Now: Buy

N/A

9.07x

11.81x

0.2

-165.0%

$-5.6

$23M

$3.90

$13M

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

$23M

$3.90

$13M

N/A

9.07x

11.81x

0.2

-165.0%

$-5.6